MSFT 435.0 0.7061% AAPL 230.65 -1.2924% NVDA 139.965 -0.9097% GOOGL 176.965 4.2934% GOOG 178.65 4.3882% AMZN 193.73 1.5197% META 594.31 0.1736% AVGO 177.28 -1.0935% TSLA 262.2401 1.0481% TSM 195.14 -0.914% LLY 831.501 -7.977% V 291.3 3.3418% JPM 224.685 0.8008% UNH 564.77 0.4696% NVO 113.15 1.0448% WMT 81.58 -0.1469% LVMUY 134.2 -1.4033% XOM 117.0342 -0.2096% LVMHF 670.0 -1.3008% MA 513.51 1.4281%

United-Guardian Inc

Consumer Defensive US UG

13.72USD
-0.17(1.22%)

Last update at 2024-10-30T17:38:00Z

Day Range

13.7214.05
LowHigh

52 Week Range

5.639.43
LowHigh

Fundamentals

  • Previous Close 13.89
  • Market Cap41.67M
  • Volume6566
  • P/E Ratio15.12
  • Dividend Yield3.94%
  • EBITDA3.17M
  • Revenue TTM11.57M
  • Revenue Per Share TTM2.52
  • Gross Profit TTM 6.70M
  • Diluted EPS TTM0.60

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 3.23M 5.88M 4.16M 6.03M 5.47M
Minority interest - - - - -
Net income 2.57M 4.66M 3.30M 4.76M 4.35M
Selling general administrative - - - 2.15M 2.12M
Selling and marketing expenses - - - - -
Gross profit 6.70M 8.18M 6.11M 7.94M 8.10M
Reconciled depreciation 0.14M 0.15M 0.17M 0.18M 0.19M
Ebit 4.04M 5.67M 3.64M 5.40M 5.50M
Ebitda 4.85M 5.46M 3.11M 4.76M 5.69M
Depreciation and amortization 0.81M -0.21084M -0.52483M -0.63440M 0.19M
Non operating income net other - - 0.52M 0.63M -0.11399M
Operating income 4.04M 5.67M 3.64M 5.40M 5.58M
Other operating expenses 8.66M 8.26M 7.35M 8.20M 8.19M
Interest expense 1.62M 0.57M 1.21M 1.44M 0.23M
Tax provision 0.66M 1.22M 0.86M 1.27M 1.11M
Interest income - - - 0.63M 0.10M
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.66M 1.22M 0.86M 1.27M 1.11M
Total revenue 12.70M 13.93M 10.99M 13.60M 13.77M
Total operating expenses 2.66M 2.51M 2.48M 2.55M 2.52M
Cost of revenue 6.00M 5.75M 4.87M 5.66M 5.67M
Total other income expense net -0.80955M 0.21M 0.52M 0.63M -0.11399M
Discontinued operations - - - - -
Net income from continuing ops 2.57M 4.66M 3.30M 4.76M 4.35M
Net income applicable to common shares 2.57M 4.66M 3.30M 4.76M 4.35M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 13.36M 10.64M 12.24M 11.92M 12.36M
Intangible assets - - - - 0.01M
Earning assets - - - - -
Other current assets 0.37M 0.20M 0.19M 0.16M 0.17M
Total liab 1.97M 1.37M 2.42M 1.57M 1.73M
Total stockholder equity 11.39M 9.27M 9.82M 10.35M 10.63M
Deferred long term liab - - - 0.15M 0.39M
Other current liab 1.36M 1.34M 1.74M 1.38M 1.27M
Common stock 0.46M 0.46M 0.46M 0.46M 0.46M
Capital stock 0.46M 0.46M 0.46M 0.46M 0.46M
Retained earnings 10.93M 8.81M 9.36M 9.89M 10.17M
Other liab - - 0.08M 0.15M 0.39M
Good will - - - - 0.01M
Other assets 0.00000M 0.11M - - 0.01M
Cash 8.24M 0.83M 0.53M 0.59M 1.05M
Cash and equivalents - - - - -
Total current liabilities 1.53M 1.37M 2.34M 1.41M 1.34M
Current deferred revenue 0.02M - 0.19M - -
Net debt -8.24312M -0.83045M -0.53121M -0.59144M -1.04831M
Short term debt 0.02M - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity - - 9.82M - 6.61M
Property plant equipment - 0.56M 0.66M 0.67M 0.78M
Total current assets 12.25M 9.97M 11.58M 11.25M 11.57M
Long term investments - - - - -
Net tangible assets - 9.27M 9.82M 10.35M 10.63M
Short term investments 0.85M 5.65M 7.64M 7.59M 6.87M
Net receivables 1.57M 1.43M 1.81M 1.39M 2.10M
Long term debt - - - - -
Inventory 1.22M 1.67M 1.41M 1.42M 1.22M
Accounts payable 0.13M 0.03M 0.41M 0.03M 0.07M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -6.60982M
Additional paid in capital - - - - -
Common stock total equity - - - 0.46M 0.46M
Preferred stock total equity - - - - -
Retained earnings total equity - - - 9.89M 10.17M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other -0.00000M - -0.08322M -0.15168M 0.01M
Deferred long term asset charges - - - - -
Non current assets total 1.11M 0.67M 0.66M 0.67M 0.80M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 0.90M -0.06710M -0.46868M 1.19M -0.23377M
Change to liabilities -0.57064M 0.57M -0.03959M -0.02692M -0.06403M
Total cashflows from investing activities 0.90M -0.18347M -0.46868M 1.07M -0.30876M
Net borrowings - - - - -
Total cash from financing activities -3.12349M -5.19003M -3.58243M -5.04992M -4.81624M
Change to operating activities -0.31460M 0.23M 0.12M 0.08M 0.17M
Net income 2.57M 4.66M 3.30M 4.76M 4.35M
Change in cash 0.30M -0.06023M -0.45687M 0.50M -0.17459M
Begin period cash flow 0.53M 0.59M 1.05M 0.55M 0.72M
End period cash flow 0.83M 0.53M 0.59M 1.05M 0.55M
Total cash from operating activities 2.53M 5.31M 3.59M 4.48M 4.95M
Issuance of capital stock - - - - -
Depreciation 0.14M 0.15M 0.17M 0.18M 0.19M
Other cashflows from investing activities - - - 1.19M -0.23377M
Dividends paid -3.12349M -5.19003M -3.58243M -5.04992M 4.82M
Change to inventory -0.29022M 0.00498M -0.19850M 0.25M -0.14163M
Change to account receivables 0.39M -0.43188M 0.72M -0.43013M 0.24M
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.90M -0.18347M -0.46868M 1.07M -0.30876M
Change to netincome 0.88M -0.05401M -0.54092M -0.29352M 0.21M
Capital expenditures 0.08M 0.12M 0.04M 0.11M 0.07M
Change receivables - - 0.72M -0.43013M 0.24M
Cash flows other operating - - -0.04921M 0.04M 0.16M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - -0.45687M 0.50M -0.17459M
Change in working capital -1.06347M 0.56M 0.66M -0.18289M -0.15524M
Stock based compensation - - - - -
Other non cash items 1.08M 0.01M -0.30575M -0.41179M 0.34M
Free cash flow 2.45M 5.20M 3.55M 4.36M 4.88M

Peer Comparison

Sector: Consumer Defensive Industry: Household & Personal Products

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
UG
United-Guardian Inc
-0.17 1.22% 13.72 15.12 - 3.23 3.09 2.39 8.78
PG
Procter & Gamble Company
-0.96 0.57% 166.21 23.58 22.62 4.07 7.24 4.40 16.08
LRLCF
L'Oréal S.A
-5.71 1.50% 374.20 41.14 34.25 6.52 8.59 6.67 27.76
LRLCY
L’Oreal Co ADR
-0.76 0.99% 75.83 41.27 33.90 6.56 8.50 6.65 27.67
UL
Unilever PLC ADR
-0.545 0.87% 61.74 13.41 15.48 1.95 5.63 2.38 10.29

Reports Covered

Stock Research & News

Profile

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL MGL, a medical lubricant with a lower viscosity medical lubricant; LUBRAJEL LC, LUBRAJEL BA, and LUBRAJEL FA, which are formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial used in urology. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and product development of cosmetic ingredients. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.

United-Guardian Inc

230 Marcus Boulevard, Hauppauge, NY, United States, 11788

Key Executives

Name Title Year Born
Ms. Donna Vigilante VP, R&D Mang. and Director of Technical Services 1980
Mr. Peter A. Hiltunen Sr. VP & Production Mang. 1959
Ms. Beatriz Blanco CEO, Pres & Director NA
Ms. Andrea J. Young CFO, Treasurer, Controller, Sec. & HR Mang. 1969
Ms. Donna Vigilante President 1981
Ms. Andrea J. Young CFO, Treasurer, Controller, Secretary & Human Resources Manager 1969
Mr. Peter A. Hiltunen Senior VP of Production & Procurement and Production Manager 1959

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.